Showing results (661-670 of 929) with videos related to
Sort By:
Pageof 93
International Clinical Psychopharmacology|August 18, 2020
Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity studyGeorge I Papakostas, Maurizio Fava, Marlene P Freeman, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2024
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled studyMark E Schmidt, Iva Kezic, Vanina Popova, et al.Nature Reviews. Disease Primers|February 17, 2017
Neuropathic painLuana Colloca, Taylor Ludman, Didier Bouhassira, et al.Plos One|June 22, 2018
Binge eating, trauma, and suicide attempt in community adults with major depressive disorderJi Hyun Baek, Kiwon Kim, Jin Pyo Hong, et al.Journal of Affective Disorders|July 10, 2002
Body dysmorphic disorder in outpatients with major depressionAndrew A Nierenberg, Katharine A Phillips, Timothy J Petersen, et al.Psychiatry Research|June 27, 2009
Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy studyMarc J Kaufman, Andrew P Prescot, Dost Ongur, et al.Journal of Psychiatric Practice|November 12, 2021
A Patient With Electroconvulsive Therapy-resistant Major Depressive Disorder With a Full Response to Heated Yoga: A Case ReportHitoshi Sakurai, Richard J Norton, Lauren B Fisher, et al.Frontiers in Psychiatry|September 23, 2022
Early psychiatric referral after attempted suicide helps prevent suicide reattempts: A longitudinal national cohort study in South KoreaHyewon Kim, Yuwon Kim, Myung-Hee Shin, et al.Sleep|October 6, 2019
Risks of suicide attempts after prescription of zolpidem in people with depression: a nationwide population study in South KoreaHyewon Kim, Yuwon Kim, Woojae Myung, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 12, 2023
Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediatorsStefania Lamon-Fava, Minying Liu, Boadie W Dunlop, et al.Pageof 93